Literature DB >> 2914299

Patterns of metastasis in uterine sarcoma. An autopsy study.

P G Rose1, M S Piver, Y Tsukada, T Lau.   

Abstract

The autopsy findings of 73 patients with uterine sarcoma were studied to determine the sites and possible modes of metastasis. Homologous mixed mesodermal tumors were the most frequent (41%) followed by leiomyosarcoma (26%), heterologous mixed mesodermal tumor (18.3%), stromal sarcoma (12%), and endolymphatic stromal myosis (3%). The peritoneal cavity and omentum were the most frequently involved sites (59%), followed by the lung (52%), pelvic lymph nodes (41%), paraaortic lymph nodes (38%), and liver parenchyma (34%). The presence of lung metastasis was not associated with pelvic or paraaortic node metastasis or intraperitoneal disease. Metastasis to other distant sites including the brain, heart, kidney, and bone were independent of pelvic and paraaortic nodal metastasis or intraperitoneal disease. Metastatic sites were not different among various histologic types. Distant metastatic sites were statistically associated with lung metastasis. Hematogenous metastasis best explains this metastatic pattern and adjuvant systemic therapy seems indicated.

Entities:  

Mesh:

Year:  1989        PMID: 2914299     DOI: 10.1002/1097-0142(19890301)63:5<935::aid-cncr2820630525>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  38 in total

1.  Skeletal muscle metastasis from uterine leiomyosarcoma.

Authors:  J M O'Brien; D D Brennan; D H Taylor; D P Holloway; B Hurson; J C O'Keane; S J Eustace
Journal:  Skeletal Radiol       Date:  2004-05-04       Impact factor: 2.199

2.  A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma.

Authors:  Oliver Zivanovic; Lindsay M Jacks; Alexia Iasonos; Mario M Leitao; Robert A Soslow; Emanuela Veras; Dennis S Chi; Nadeem R Abu-Rustum; Richard R Barakat; Murray F Brennan; Martee L Hensley
Journal:  Cancer       Date:  2011-07-12       Impact factor: 6.860

3.  Diplopia with a Cavernous Sinus Metastasis of a Remote Endometrial Stromal Tumour.

Authors:  Nisha X Jain; Michael Morgan; Joseph Corbo; Aseem Sharma; Gregory P Van Stavern
Journal:  Neuroophthalmology       Date:  2013-09-24

4.  Adjuvant treatment of proper endobronchial management in leiomyosarcoma.

Authors:  Soo Jung Kim; Junghyun Kim; Ju-Hee Park; Ae-Ra Lee; Jung-Kyu Lee; Tae Min Kim; Young Sik Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-12-24

Review 5.  Tamoxifen in breast cancer ipse dixit in uterine malignant mixed Müllerian tumor and sarcoma-A report of 8 cases and review of the literature.

Authors:  Ana Luisa Cardoso Vasconcelos; Beatriz Nunes; Catarina Duarte; Vera Mendonça; Joana Ribeiro; Marília Jorge; Isabel Monteiro Grillo
Journal:  Rep Pract Oncol Radiother       Date:  2013-08-12

6.  Sarcomatous lesions in CBA female mice treated with 1,2-dimethylhydrazine: independent primaries or metastases?

Authors:  L S Trukhanova; V S Turusov
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

7.  18F-fluorodeoxyglucose positron emission tomography in uterine carcinosarcoma.

Authors:  Kung-Chu Ho; Chyong-Huey Lai; Tzu-I Wu; Koon-Kwan Ng; Tzu-Chen Yen; Gigin Lin; Ting-Chang Chang; Chun-Chieh Wang; Swei Hsueh; Huei-Jean Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-19       Impact factor: 9.236

8.  Perforated intestinal leiomyosarcoma as a metastasis of uterine leiomyosarcoma: a case report.

Authors:  Bariş Saylam; Omer Vefik Ozozan; Arife Polat Düzgün; Bahadir Külah; Ozge Han; Faruk Coşkun
Journal:  Cases J       Date:  2009-09-17

9.  Undifferentiated uterine sarcoma metastatic to the brain.

Authors:  Douglas L Stofko
Journal:  Surg Neurol Int       Date:  2013-09-27

10.  Cutaneous skull metastasis from uterine leiomyosarcoma: a case report.

Authors:  Nikolaos Barbetakis; Dimitrios Paliouras; Christos Asteriou; Georgios Samanidis; Athanassios Kleontas; Doxakis Anestakis; Kostas Kaplanis; Christodoulos Tsilikas
Journal:  World J Surg Oncol       Date:  2009-05-11       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.